ReviewCureus2025
Bibliometric Analysis of Small-Cell Lung Cancer in Geriatric Populations.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to analyze the literature published about small-cell lung cancer (SCLC) in geriatric populations on a global scale from 1979 to 2023. This bibliometric analysis was performed by gathering data from the Web of Science Core Data Collection, using keywords such as small-cell lung cancer, SCLC, extensive-stage SCLC (ES-SCLC), and oat cell cancer. The search was further refined to target an older adult population by incorporating keywords such as 65+ years of age, geriatric patients, and baby boomers. These articles were then analyzed using VOSviewer. Maps were generated using sorting methods, focusing specifically on organizations, countries, and keywords. More than 7,710 articles spanning from 1979 to 2023 were analyzed. The United States, the People's Republic of China, and Japan produced the most publications on small-cell lung cancer in geriatric patients. When analyzing keywords used in studies on small-cell lung cancer in geriatric patients, many were related to the treatment and therapy of the disease. This bibliometric analysis shows that as time progresses, the focus of the United States, the People's Republic of China, and Japan is to increase research on therapeutics and treatments to help remedy small-cell lung cancer in order to decrease fatal lung cancer diagnoses in geriatric patients. If these countries continue their research efforts as before, more advancements in treatment can be made to ultimately find a cure for small-cell lung cancer, particularly impacting geriatric populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.